Publications
5539 Results
- Journal / Conference
- Investigational New Drugs 20:419-424
- Year
- 2002
- Research Committee(s)
- Gastrointestinal
- Study Number(s)
- S9635
Biochemical modulation of 5-fluorouacil through dihydropyrimidine dehydrogenase inhibition: a Southwest Oncology Group phase II trial of eniluracil and 5-fluorouracil in advanced resistant colorectal cancer.
- Journal / Conference
- Gynecologic Oncology 86:239-243
- Year
- 2002
- Research Committee(s)
- Gynecologic
- Study Number(s)
- SWOG-8412, SWOG-8501 (INT-0051)
Prediction of the need for red cell transfusion in newly diagnosed ovarian cancer patients undergoing platinum-based treatment.
- Journal / Conference
- Modern Pathology 15(1):240a(#1002)
- Year
- 2002
- Research Committee(s)
- Lymphoma
- Study Number(s)
- SWOG-8819
Failure of beta-globin gene detection does not predict non-amplification of DNA in JH/Bcl-2 PCR Analysis: insights from a national follicular lymphoma clinical trial
- Journal / Conference
- Modern Pathology 15(1):237a(#991)
- Year
- 2002
- Research Committee(s)
- Lymphoma
- Study Number(s)
- SWOG-8819
Gene expression profiling in laser microdissected normal follicular mantles, mantle cell lymphoma (MCL), and blastoid variant of mantle cell lymphoma
- Journal / Conference
- Journal of Urology 168:2016-2019
- Year
- 2002
- Research Committee(s)
- Genitourinary
- Study Number(s)
- SWOG-9109
Neoadjuvant therapy before radical prostatectomy for clinical T3/T4 carcinoma of the prostate: 5 year follow-up, phase II SWOG study 9109
- Journal / Conference
- Annals of Surgical Oncology 9(1)Suppl:S24(#52)
- Year
- 2002
- Research Committee(s)
- Gastrointestinal
- Study Number(s)
- SWOG-9041
Adenoma recurrences after resection of colorectal carcinoma (CRC). Results from the SWOG 9041 calcium chemoprevention pilot study.
- Journal / Conference
- Annals of Oncology 13:1576-1582
- Year
- 2002
- Research Committee(s)
- Gastrointestinal
- Study Number(s)
- S9629
Phase II trial of 5-fluorouracil plus eniluracil in patients with advanced pancreatic cancer: a Southwest Oncology Group study
- Journal / Conference
- Cancer 95(5):1101-1112
- Year
- 2002
- Research Committee(s)
- Melanoma
- Study Number(s)
- SWOG-9325 (EST-2690)
Immunomodulatory effects of high-dose and low-dose interferon a2b in patients with high-risk resected melanoma: the E2690 laboratory corollary of Intergroup adjuvant trial E1690
- Journal / Conference
- Journal of Clinical Oncology 20(8):2053-2057
- Year
- 2002
- Research Committee(s)
- Melanoma
- Study Number(s)
- SWOG-9111 (EST-1690)
Implications of microscopic satellites of the primary and extracapsular lymph node spread in patients with high-risk melanoma: pathologic corollary of Eastern Cooperative Oncology Group Trial E1690
- Journal / Conference
- Proc of the American Society of Clinical Oncology 21:227a(#907)
- Year
- 2002
- Research Committee(s)
- Head and Neck
- Study Number(s)
- E1395